Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) just unveiled an update.
JOINN Laboratories (China) Co., Ltd. released its first quarterly report for 2025, revealing a decrease in revenue by 11.54% compared to the same period last year. Despite this, the company reported a significant improvement in net profit attributable to shareholders, which increased by 115.11%, indicating a recovery from previous losses. The report highlights a decline in net cash flow from operating activities by 45.69%, but an increase in basic and diluted earnings per share by 113.89%. These financial results suggest a positive turnaround in profitability, although challenges in cash flow remain.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the laboratory and research industry. The company is focused on providing laboratory services and research support, with a market presence in China and listed on the Hong Kong Stock Exchange.
YTD Price Performance: 6.95%
Average Trading Volume: 4,551,252
Technical Sentiment Signal: Buy
Current Market Cap: HK$11.61B
For detailed information about 6127 stock, go to TipRanks’ Stock Analysis page.